2min chapter

Blood Cancer Talks cover image

Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma

Blood Cancer Talks

CHAPTER

The Differences Between CARMA 3 and CARTUT4

In CARMA 3, the control arm was a little bit more ingenious. It was pretty much ciltacil versus darapomb-dex-trial. Do you think if daracadia or isa-kady was in the control arm, some of the benefit of CART would have been attenuated? I mean, that's a little bit hard to speculate. But your point is well taken.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode